...
首页> 外文期刊>癌と化学療法 >A case report of poorly-differentiated adenocarcinoma in sigmoid colon cancer with liver and pulmonary metastasis responding to TS-1 and CPT-11
【24h】

A case report of poorly-differentiated adenocarcinoma in sigmoid colon cancer with liver and pulmonary metastasis responding to TS-1 and CPT-11

机译:乙状结肠癌低分化腺癌伴TS-1和CPT-11肝,肺转移的一例报告

获取原文
获取原文并翻译 | 示例
           

摘要

A 66-year-old woman (156 cm, 58 kg) underwent sigmoid colectomy for cancer. She was found to have simultaneous liver and peritoneal metastases at operation, which had not been detected with CT examination before operation. After operation, CT showed multiple liver metastasis and a high level of CEA and CA19-9 . Pathological findings were type 3, 30 x 20 mm, poorly-differentiated adenocarcinoma, se, ly 2, v 2, n 2 (+), ow (-), aw(-), H 3, P 0 (stage IV). Treatment of the patient consisted of daily oral administration of 80 mg TS-1 for 21 days and 60 mg CPT-11 on 1 day and 15 day as one course.After 2 courses, tumor sizes of liver metastases and the level of tumor markers became reduced.The current case suggested that the administration of TS-1 and CPT-11 may have a potent therapeutic efficacy in advanced colorectal cancer.
机译:一名66岁的女性(156厘米,58公斤)接受了乙状结肠癌切除术。术中发现她同时有肝和腹膜转移,术前CT检查未发现。术后CT显示多发肝转移和高水平的CEA和CA19-9。病理结果为3型,30 x 20 mm,低分化腺癌,se,ly 2,v 2,n 2(+),ow(-),aw(-),H 3,P 0(IV期)。该患者的治疗包括每天口服80 mg TS-1持续21天,在1天和15天每日60 mg CPT-11作为一个疗程.2个疗程后,肝转移瘤的大小和肿瘤标志物的水平变为目前的病例表明,TS-1和CPT-11的给药可能对晚期大肠癌具有有效的治疗作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号